跳至主要内容
临床试验/NCT03241030
NCT03241030已完成2 期

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial

University of Texas at Austin1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2017年9月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
102
试验地点
1
主要终点
Oral Intake in ml/kg

研究概览

简要总结

The purpose of this study is to see if sucralfate, a medication commonly used for patients with stomach ulcers, may help pediatric patients with mouth ulcers decrease their pain level and improve their ability to drink.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age ≥6 months and ≤5 years old
  • Present with oral infectious ulcers such as gingivostomatitis, herpangina, or hand, foot and mouth disease
  • History of decreased oral fluid intake by parent or guardian
  • English or Spanish speaking parents or guardians

排除标准

  • Severely dehydrated or toxic, requiring immediate resuscitation
  • Exclusively breastfed
  • Severe dental disease
  • Significant mouth trauma
  • Active Malignancy
  • Preexisting upper airway obstruction or swallowing difficulties
  • Received intravenous fluids within 24 hours
  • Administration of BOTH acetaminophen AND ibuprofen prior to triage and within 4 hours of enrollment

研究组 & 干预措施

Experimental Group

Experimental

Subjects will receive sucralfate

干预措施: Sucralfate (Drug)

Experimental Group

Experimental

Subjects will receive sucralfate

干预措施: Acetaminophen (Drug)

Experimental Group

Experimental

Subjects will receive sucralfate

干预措施: Ibuprofen (Drug)

Placebo Group

Placebo Comparator

Subjects will receive a placebo

干预措施: Placebo (Other)

Placebo Group

Placebo Comparator

Subjects will receive a placebo

干预措施: Acetaminophen (Drug)

Placebo Group

Placebo Comparator

Subjects will receive a placebo

干预措施: Ibuprofen (Drug)

结局指标

主要结局

Oral Intake in ml/kg

时间窗: Approximately 60 minutes after medication administration.

Will quantify the amount (in ml/kg) of liquid ingested after intervention.

次要结局

  • Number of Participants That Require Intravenous Fluid Administration(6 hours from the time of enrollment)
  • Number of Participants That Require Admission(6 hours from the time of enrollment)
  • Number of Participants With Unscheduled Visits(Approximately 72 hours from ED visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nidhi Vaidya

Resident

University of Texas at Austin

研究点 (1)

Loading locations...

相似试验

Sucralfate to Improve Oral Intake in Children With... | 临床试验